Skip to content

Clinical trials

Completed Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Status: Completed Country / region: Singapore Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20053
20063
20073
20082
20101
20111
20121
20133
20142
20151
20161
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Bristol-Myers Squibb5
Pfizer5
Singapore General Hospital2
Teva Branded Pharmaceutical Products R&D, Inc.2
Ariad Pharmaceuticals1
Gamida Cell ltd1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive24
Leukemia4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Bone Marrow Diseases3
Leukemia, Myeloid3
Gastrointestinal Stromal Tumors2
Hematologic Diseases2
Hematologic Neoplasms2
Leukemia, Myeloid, Acute2
Myelodysplastic Syndromes2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.